FDA advisers recommend 2nd coronavirus vaccine, with agency approval expected soon
A government advisory panel endorsed a second COVID-19 vaccine Thursday, paving the way for the shot to be added to the U.S. vaccination campaign.
A government advisory panel endorsed a second COVID-19 vaccine Thursday, paving the way for the shot to be added to the U.S. vaccination campaign.
A spokesperson for Australian manufacturer Ellume said the test will be priced around $30 and be available at pharmacies and for purchase online.
Pfizer’s COVID-19 vaccine faces one final hurdle as it races to become the first shot greenlighted in the U.S.: a panel of experts who will scrutinize the company’s data for any red flags.
Documents released by U.S. regulators Tuesday confirmed that Pfizer’s vaccine was strongly protective against COVID-19 and appeared safe.
The Food and Drug Administration released updated safety standards Tuesday for makers of COVID-19 vaccines after the White House blocked their formal release, the latest political tug-of-war between the Trump administration and the government’s public health scientists.
The whole enterprise is facing public skepticism. Only about half of Americans said they’d get vaccinated in one poll.
Experts think last year’s outbreak of vaping related illnesses and deaths may have scared off some kids, but they believe higher age limits and flavor bans also contributed.
Scientists and medical experts have been pushing back against the claims about the treatment since President Trump's announcement Sunday that the FDA had decided to issue emergency authorization for convalescent plasma.
There will be a priority list for who gets early vaccinations. "I don't think we will have everybody getting it immediately," Fauci told a congressional committee.
Preliminary results from a study showed that the drug, remdesivir, shortened the time to recovery by 31% for hospitalized patients.
The shortages are the latest stumble in a botched effort to track the spread of coronavirus that has left the U.S. weeks behind many other developed countries.
Juul Labs stopped selling fruit and dessert flavors Thursday, acknowledging the public’s “lack of trust” in the vaping industry.